Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Plasmodium falciparum | bifunctional dihydrofolate reductase-thymidylate synthase | Curated by TDR Targets | References |
Cavia porcellus | Cholecystokinin A receptor | Starlite/ChEMBL | References |
Rattus norvegicus | Cholecystokinin A receptor | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Mycobacterium ulcerans | thymidylate synthase | 0.013 | 0.2317 | 1 |
Schistosoma mansoni | bifunctional dihydrofolate reductase-thymidylate synthase | 0.013 | 0.2317 | 1 |
Onchocerca volvulus | 0.013 | 0.2317 | 0.5 | |
Echinococcus multilocularis | short transient receptor potential channel 6 | 0.0014 | 0.002 | 0.0085 |
Loa Loa (eye worm) | thymidylate synthase | 0.013 | 0.2317 | 0.2317 |
Mycobacterium leprae | PROBABLE THYMIDYLATE SYNTHASE THYA (TS) (TSASE) | 0.013 | 0.2317 | 1 |
Mycobacterium tuberculosis | Hypothetical protein | 0.0062 | 0.0966 | 0.1148 |
Trypanosoma cruzi | dihydrofolate reductase-thymidylate synthase | 0.0183 | 0.3368 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0062 | 0.0966 | 0.5 |
Trypanosoma brucei | dihydrofolate reductase-thymidylate synthase | 0.0183 | 0.3368 | 0.5 |
Brugia malayi | sulfakinin receptor protein | 0.0517 | 1 | 1 |
Toxoplasma gondii | bifunctional dihydrofolate reductase-thymidylate synthase | 0.0183 | 0.3368 | 0.5 |
Plasmodium falciparum | bifunctional dihydrofolate reductase-thymidylate synthase | 0.0183 | 0.3368 | 0.5 |
Echinococcus multilocularis | dihydrofolate reductase | 0.0053 | 0.0791 | 0.3414 |
Echinococcus multilocularis | transient receptor potential cation channel | 0.0014 | 0.002 | 0.0085 |
Loa Loa (eye worm) | hypothetical protein | 0.0517 | 1 | 1 |
Chlamydia trachomatis | dihydrofolate reductase | 0.0053 | 0.0791 | 0.5 |
Echinococcus granulosus | transient receptor potential cation channel | 0.0014 | 0.002 | 0.0085 |
Schistosoma mansoni | dihydrofolate reductase | 0.0053 | 0.0791 | 0.3414 |
Plasmodium vivax | bifunctional dihydrofolate reductase-thymidylate synthase, putative | 0.0183 | 0.3368 | 0.5 |
Brugia malayi | dihydrofolate reductase family protein | 0.0053 | 0.0791 | 0.0773 |
Echinococcus multilocularis | transient receptor potential cation channel | 0.0014 | 0.002 | 0.0085 |
Echinococcus granulosus | thymidylate synthase | 0.013 | 0.2317 | 1 |
Loa Loa (eye worm) | dihydrofolate reductase | 0.0053 | 0.0791 | 0.0791 |
Leishmania major | dihydrofolate reductase-thymidylate synthase | 0.0183 | 0.3368 | 0.5 |
Brugia malayi | hypothetical protein | 0.0062 | 0.0966 | 0.0948 |
Echinococcus granulosus | short transient receptor potential channel 6 | 0.0014 | 0.002 | 0.0085 |
Brugia malayi | Dihydrofolate reductase | 0.0053 | 0.0791 | 0.0773 |
Mycobacterium tuberculosis | Probable thymidylate synthase ThyA (ts) (TSASE) | 0.013 | 0.2317 | 1 |
Echinococcus multilocularis | thymidylate synthase | 0.013 | 0.2317 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0014 | 0.002 | 0.002 |
Echinococcus granulosus | dihydrofolate reductase | 0.0053 | 0.0791 | 0.3414 |
Schistosoma mansoni | transient receptor potential channel | 0.0014 | 0.002 | 0.0085 |
Brugia malayi | thymidylate synthase | 0.013 | 0.2317 | 0.2302 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 9.3 uM | Inhibition of binding of [125I]- CCK-33 to rat pancreas | ChEMBL. | 2299627 |
IC50 (binding) | = 9.3 uM | Inhibition of binding of [125I]- CCK-33 to rat pancreas | ChEMBL. | 2299627 |
IC50 (binding) | = 16 uM | Inhibition of binding of [125I]- CCK-33 to guinea pig cortex | ChEMBL. | 2299627 |
IC50 (binding) | = 16 uM | Inhibition of binding of [125I]- CCK-33 to guinea pig cortex | ChEMBL. | 2299627 |
IC50 (binding) | = 44 uM | Inhibition of binding of [125I]-gastrin to Cholecystokinin type B receptor from guinea pig gastric glands | ChEMBL. | 2299627 |
IC50 (binding) | = 44 uM | Inhibition of binding of [125I]-gastrin to Cholecystokinin type B receptor from guinea pig gastric glands | ChEMBL. | 2299627 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.